CY1105204T1 - Γονιδιο υψηλης εκφρασης σε ιστους χονδρων - Google Patents

Γονιδιο υψηλης εκφρασης σε ιστους χονδρων

Info

Publication number
CY1105204T1
CY1105204T1 CY20061101188T CY061101188T CY1105204T1 CY 1105204 T1 CY1105204 T1 CY 1105204T1 CY 20061101188 T CY20061101188 T CY 20061101188T CY 061101188 T CY061101188 T CY 061101188T CY 1105204 T1 CY1105204 T1 CY 1105204T1
Authority
CY
Cyprus
Prior art keywords
polypeptides
present
highly expressed
nucleic acid
cartilage tissues
Prior art date
Application number
CY20061101188T
Other languages
English (en)
Inventor
Ellen Filvaroff
Audrey Goddard
J. Christopher Grimaldi
William I. Wood
Original Assignee
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech, Inc. filed Critical Genentech, Inc.
Publication of CY1105204T1 publication Critical patent/CY1105204T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)

Abstract

Η παρούσα εφεύρεση αφορά πρωτότυπα πολυπεπτίδια που έχουν ομοιότητα αλληλουχίας με inter-άλφα αναστολέα θρυψίνης (inter-alpha-trypsin inhibitor) και μόρια νουκλεϊκών οξέων που κωδικοποιούν αυτά τα πολυπεπτίδια. Παρέχονται επίσης εδώ φορείς και κύτταρα-ξενιστές που περιλαμβάνουν αυτές τις αλληλουχίες νουκλεϊκών οξέων, μόρια χιμαιρικών πολυπεπτιδίων που περιλαμβάνουν τα πολυπεπτίδια της παρούσας εφεύρεσης συντηγμένα με αλληλουχίες ετερόλογων πολυπεπτιδίων, αντισώματα που δεσμεύονται με τα πολυπεπτίδια της παρούσας εφεύρεσης και μέθοδοι παραγωγής των πολυπεπτιδίων της παρούσας εφεύρεσης. Επιπλέον παρέχονται εδώ μέθοδοι χρήσης του πολυπεπτιδίου για διάγνωση και θεραπευτική αγωγή βλάβης σε χόνδρο που προκύπτει από κάκωση και/ή χόνδρινες ανωμαλίες.
CY20061101188T 2000-12-08 2006-08-24 Γονιδιο υψηλης εκφρασης σε ιστους χονδρων CY1105204T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25451300P 2000-12-08 2000-12-08
PCT/US2001/047933 WO2002059308A2 (en) 2000-12-08 2001-12-07 Method of diagnosing and treating cartilage disorders

Publications (1)

Publication Number Publication Date
CY1105204T1 true CY1105204T1 (el) 2010-03-03

Family

ID=22964573

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101188T CY1105204T1 (el) 2000-12-08 2006-08-24 Γονιδιο υψηλης εκφρασης σε ιστους χονδρων

Country Status (13)

Country Link
US (1) US20070160594A1 (el)
EP (1) EP1364023B1 (el)
JP (1) JP2005501513A (el)
AT (1) ATE329026T1 (el)
AU (1) AU2002246633B2 (el)
CA (1) CA2426102A1 (el)
CY (1) CY1105204T1 (el)
DE (1) DE60120500T2 (el)
DK (1) DK1364023T3 (el)
ES (1) ES2269509T3 (el)
IL (2) IL155567A0 (el)
PT (1) PT1364023E (el)
WO (1) WO2002059308A2 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932365B2 (en) 2003-11-08 2011-04-26 Pro Thera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
WO2007149328A1 (en) * 2006-06-20 2007-12-27 Genzyme Corporation Serum-free media and their uses for chondrocyte expansion
EP2147311A4 (en) * 2007-04-26 2010-08-11 Genera Istrazivanja D O O BLOOD BIOMARKER FOR BONE BREAKING AND BODILY INJURY
KR101714008B1 (ko) 2008-05-28 2017-03-09 프로테라 바이오로직스, 인크. 혈액으로부터 인터-알파 저해 단백질의 제조 및 조성물
EP2343087B1 (en) * 2008-09-30 2018-07-18 Oriental Yeast Co., Ltd. Novel inducer of chondrocyte proliferation and differentiation
CA2743768A1 (en) * 2008-12-10 2010-06-17 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease
CN101972471B (zh) * 2010-10-08 2013-09-25 广东天普生化医药股份有限公司 乌司他丁用于制备治疗自身免疫性脑脊髓炎药物的用途及其药物组合物
CN101954071B (zh) * 2010-10-08 2013-09-25 广东天普生化医药股份有限公司 乌司他丁作为制备治疗系统性红斑狼疮药物的用途及其药物组合物
WO2012167226A2 (en) 2011-06-03 2012-12-06 Maguire Abbey, Llc Method, composition, and articles for improving joint lubrication
AU2013312215C1 (en) 2012-09-09 2018-09-06 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
US10125349B2 (en) 2013-03-28 2018-11-13 Ge Healthcare Bio-Sciences Ab Method for cell culture
US9944895B2 (en) 2013-03-28 2018-04-17 Ge Healthcare Bio-Sciences Ab Method for cell culture
CN105770875A (zh) * 2016-03-17 2016-07-20 广东天普生化医药股份有限公司 乌司他丁在制备治疗食管癌药物中的用途
CN105770874A (zh) * 2016-03-17 2016-07-20 广东天普生化医药股份有限公司 乌司他丁在制备治疗多发性硬化药物中的用途
CN105816862A (zh) * 2016-03-17 2016-08-03 广东天普生化医药股份有限公司 乌司他丁在制备治疗前列腺癌药物中的用途
CN105770877A (zh) * 2016-05-30 2016-07-20 广东天普生化医药股份有限公司 乌司他丁在制备治疗膀胱癌药物中的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5444047A (en) * 1994-06-16 1995-08-22 Dipasquale; Gene Treatment of arthritic and post-surgical orthopedic conditions with Insulin-like Growth Factor-I

Also Published As

Publication number Publication date
IL155567A0 (en) 2003-11-23
DE60120500T2 (de) 2007-06-06
EP1364023B1 (en) 2006-06-07
DE60120500D1 (de) 2006-07-20
ATE329026T1 (de) 2006-06-15
WO2002059308A2 (en) 2002-08-01
PT1364023E (pt) 2006-10-31
AU2002246633B2 (en) 2007-07-19
EP1364023A2 (en) 2003-11-26
ES2269509T3 (es) 2007-04-01
JP2005501513A (ja) 2005-01-20
IL155567A (en) 2008-12-29
DK1364023T3 (da) 2006-10-09
CA2426102A1 (en) 2002-08-01
WO2002059308A3 (en) 2003-09-18
US20070160594A1 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
CY1105204T1 (el) Γονιδιο υψηλης εκφρασης σε ιστους χονδρων
CY1122242T1 (el) Ετερολογα πολυπεπτιδια il-17a/f
CY1112334T1 (el) Ομολογα πολυπεπτιδια il-17 και θεραπευτικες χρησεις αυτων
CY1106885T1 (el) Θεραπευτικες χρησεις il-17-ομολογων πολυπεπτιδιων
DE60235039D1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
DE60042969D1 (de) Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
DE69635444D1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
DE69839942D1 (de) Verwendung des wnt-1 induzierten sekretierten polypeptids wisp-1
DE60042799D1 (de) Methoden zur Diagnose von Tumoren
DE69941273D1 (de) Zusammenstellung und Verfahren zur Diagnose von Tumoren
CA2390685A1 (en) Methods and compositions for inhibiting neoplastic cell growth
DK1366161T3 (da) Antagonist anti-PRO842-antistof
WO2003076569A3 (en) Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
WO1999042586A3 (en) Exo1 and exo2, exocytotic proteins
DE69939989D1 (de) Menschliches gas-6 (growth arrest-specific gene 6) Protein und dafür kodierende Nukleinsäuren
DK1241252T3 (da) Nucleinsyrer, der opformeres i tumorer samt relaterede materialer og fremgangsmåder
DK1277833T3 (da) Gener, der opformeres i tumorer, samt relaterede materialer og metoder
DK1249491T3 (da) Nucleinsyre, der opformeres i humane tumorer samt beslægtede materialer og fremgangsmåder
DK1300417T3 (da) Secerneret og transmembrant polypeptid og nucleinsyre kodende derfor
DE69937756D1 (de) Menschliches Prostasin-ähnliches Protein und dafür kodierende Nukleinsäure
DK1241184T3 (da) Humant synaptogyrin-lignende protein og nukleinsyrer kodende for dette
DK1241185T3 (da) Nucleinsyrer, der er opformeret i humane tumorer, samt beslægtede materialer og fremgangsmåder
CY1105580T1 (el) Νεα μορια κινασης πρωτεϊνης 14911 και χρησεις τους
CY1114264T1 (el) Σταθερα και διαλυτα αντισωματα που αναστελλουν τον tnf (αλφα)
DE69939403D1 (de) Menschliches HCAR-ähnliches Protein und dafür kodierende Nukleinsäure